Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified

• Main Authors: Baum SJ (Author), Wade RL (Author), Xiang P (Author), Arellano J (Author), Cerezo Olmos C (Author), Nunna S (Author), Chen CC (Author), Carter CM (Author), Desai NR (Author)
• Format: Book
• Published: Dove Medical Press, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Seth J Baum,1,2 Rolin L Wade,3 Pin Xiang,4 Jorge Arellano,4 Cesar Cerezo Olmos,5 Sasikiran Nunna,6 Chi-Chang Chen,6 Cathryn M Carter,7 Nihar R Desai8 1Department of Integrated Medical Sciences, Charles E Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA; 2Preventive Cardi...